SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • July 31st, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of July 1, 2009, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Peter T. Slover (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Change in Control Agreement between Executive (then a senior employee) and the Company entered into as of March 4, 2008 (the “Original Agreement”).
SUBLEASE AGREEMENTSublease Agreement • July 31st, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This SUBLEASE AGREEMENT (“Sublease”) is made as of the 18th day of June, 2009 (“Effective Date”), by and between PHENOMIX CORPORATION, a Delaware corporation (the “Sublandlord”) and ANADYS PHARMACEUTICALS, INC., a Delaware corporation (the “Subtenant”) with regard to the following facts.
June 2nd, 2009 James T. Glover, CPA c/o Anadys Pharmaceuticals, Inc. 3115 Merryfield Row, San Diego, CA 92121 Re: Severance Agreement and General Release Dear Jim:Anadys Pharmaceuticals Inc • July 31st, 2009 • Pharmaceutical preparations • California
As we discussed, in connection with the Anadys Pharmaceuticals, Inc. (the “Company”) restructuring and reduction in force, your employment with the Company will terminate on June 30th, 2009 (“Separation Date”). This letter will set forth our proposed agreement concerning your separation from the Company, severance benefits from the Company and your release of the Company from any obligations or claims after the Separation Date.
